Physician profile
Patrick Showalter
NPI 1558343830
$1,022.13
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $209 · 2022: $60.97 · 2023: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $165 · Food and Beverage: $40.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $164.99 |
| Food and Beverage | $40.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $434.23 | 2019-2023 | |
| Boston Scientific Corporation | $159.57 | 2019-2023 | Advantage System, Solyx Sis System |
| Neotract INC. | $137.03 | 2019 | |
| Abbvie INC. | $104.22 | 2019-2020 | |
| Olympus America INC. | $33.06 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $29.49 | 2019-2020 | |
| Pfizer INC. | $24.46 | 2019 | |
| Allergan, INC. | $24.35 | 2022 | |
| Janssen Biotech, INC. | $22.59 | 2019 | |
| Ambu INC. | $18.72 | 2022 | |
| Urovant Sciences INC | $17.90 | 2022 | |
| Merck Sharp & Dohme LLC | $16.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Showalter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.